Bellevue Group Ag has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $5.02 Billion distributed in 193 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Argenx Se with a value of $365M, Ionis Pharmaceuticals Inc with a value of $275M, Neurocrine Biosciences Inc with a value of $248M, Intuitive Surgical Inc with a value of $242M, and Intra Cellular Therapies, Inc. with a value of $204M.
Examining the 13F form we can see an decrease of $914M in the current position value, from $5.93B to 5.02B.
Bellevue Group Ag is based out at Kuesnacht, V8
Below you can find more details about Bellevue Group Ag portfolio as well as his latest detailed transactions.
Portfolio value
$5.02 Billion
Healthcare: $5.01 Billion
ETFs: $4.21 Million
Communication Services: $1.31 Million
Technology: $577,000
Stock Holdings Table Market Cap. of $2 Billions to $10 Billions
